Off-label use of intravenous thrombolysis for acute ischemic stroke: a critical appraisal of randomized and real-world evidence

Intravenous thrombolysis (IVT) represents the only systemic reperfusion therapy able to reverse neurological deficit in patients with acute ischemic stroke (AIS). Despite its effectiveness in patients with or without large vessel occlusion, it can be offered only to a minority of them, because of th...

Descripción completa

Detalles Bibliográficos
Autores principales: Tsivgoulis, Georgios, Kargiotis, Odysseas, De Marchis, Gianmarco, Kohrmann, Martin, Sandset, Else Charlotte, Karapanayiotides, Theodore, de Sousa, Diana Aguiar, Sarraj, Amrou, Safouris, Apostolos, Psychogios, Klearchos, Vadikolias, Konstantinos, Leys, Didier, Schellinger, Peter D., Alexandrov, Andrei V.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7934037/
https://www.ncbi.nlm.nih.gov/pubmed/33737956
http://dx.doi.org/10.1177/1756286421997368

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7934037/
https://www.ncbi.nlm.nih.gov/pubmed/33737956
http://dx.doi.org/10.1177/1756286421997368

Ejemplares similares